EMEA-002259-PIP01-17

Table of contents

Key facts

Active substance
Levothyroxine (sodium)
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0096/2018
PIP number
EMEA-002259-PIP01-17
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
  • Treatment of benign thyroid nodules
  • Treatment of goitre
  • Treatment of hypothyroidism
Route(s) of administration
Oral use
Contact for public enquiries
IBSA Institut Biochimique SA

Tel. +41 5836 01718
E-mail: giulia.petricca@ibsa.ch

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating
Average
1 rating